TRAJENTA®: Favourable safety and tolerability for a broad range of patients.
TRAJENTA® has demonstrated a favourable safety and tolerability profile, with an incidence of adverse events similar to placebo.1
Please see the Summary of Product Characteristics for more information.
With one dose, once daily, TRAJENTA® can be prescribed regardless of disease duration, ethnicity, body mass index (BMI), liver and kidney function.1
Want to understand more about the safety of TRAJENTA®?